FDA Adverse Event Malfunction Summary report: N

TPUC3

MDR report key: 20106130 · Received August 30, 2024

Report

Report Number
1823260-2024-02512
Event Type
Malfunction
Date Received
August 30, 2024
Date of Event
August 7, 2024
Report Date
February 24, 2025
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JGQ
PMA / PMN Number
K071239
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE TPUC3 REAGENT EXPIRATION DATE WAS NOT PROVIDED. THE C702 MODULE SERIAL NUMBER WAS (B)(6). THE CUSTOMER USES A 3RD PARTY QC. QC WAS WITHIN THE ASSIGNED RANGES ON THE DAY OF THE EVENT. THE ALARM TRACE SHOWED MULTIPLE ABNORMAL ASPIRATION (SAMPLE PROBE) ALARMS, A SAMPLE CLOT ALARM, AND A COUPLE OF SAMPLE SHORT ALARMS. THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

THERE WAS FLUCTUATION AT THE BEGINNING OF THE CALIBRATION TRACE BUT THEN IT BECAME STABLE WITHIN SPECIFICATIONS. THE REACTION KINETICS SHOWED A VERY STRONG ABNORMAL COURSE. SUCH CURVES ARE USUALLY TRIGGERED BY GAMMOPATHY. GAMMOPATHY IS INCREASINGLY OBSERVED IN PATIENTS DIAGNOSED WITH CANCER, WHICH WAS SUPPORTED IN THIS EVENT. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT WAS CONSISTENT WITH A SAMPLE-RELATED (E.G. GAMMOPATHY) AND A PREANALYTIC ISSUE AT THE CUSTOMER SITE. PREANALYTICS ARE WITHIN THE CUSTOMER'S RESPONSIBILITY.

Description of Event or Problem · 0

WE RECEIVED AN ALLEGATION ABOUT DISCREPANT RESULTS FOR 1 PATIENT URINE SAMPLE TESTED WITH TOTAL PROTEIN URINE/CSF GEN.3 (TPUC3) ASSAY ON A COBAS 8000 C702 MODULE. RANDOM RESULT: 21.7 MG/DL. 24 HOURS RESULT: 0.0 MG/DAY. NO QUESTIONABLE RESULT WAS REPORTED OUTSIDE THE LABORATORY. THE RESULT OF 21.7 MG/DL WAS REPORTED OUTSIDE THE LABORATORY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1912248 TPUC3 TOTAL PROTEIN JGQ ROCHE DIAGNOSTICS 767916

Patients

Seq Age Sex Outcome Treatment
1 NA Male